Catherine Coombs, MD, of the University of California, Irvine, discusses Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia (CLL) at the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.